Candel Therapeutics

Developer of viral immunotherapies for the treatment of cancer

placeUnited States calendar_todayFounded 1999 groups76 employees language candeltx.com

Registered entities

Social engagement

Social engagement: 13.1K social following, 7 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; lead investors include PBM Capital.

Investor typeCountShare
Venture capital350%
Private equity117%
Other / undisclosed233%

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

24 Jun 2026 · Senior Director, QC Laboratory · Needham, Massachusetts

23 Jun 2026 · Senior Scientist I, Quality Control · Needham, Massachusetts

13 Mar 2026 · Clinical Scientist · Needham

6 Feb 2026 · Staff Accountant · Needham

27 Jan 2026 · Manufacturing Specialist, External Manufacturing Quality- Contract · Needham

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Milestone
regulatory
25 Jun 2026
Leadership hire
Chief Commercial Officer
24 Jun 2026
Event
2026 Society for Immunotherapy of Cancer (SITC) Biotech Strategic Meeting
Coming soon